【摘要】 目的 :系统评价补肾活血类中药复方治疗良性前列腺增生 (BPH)的疗效和不良反应 ,以期指导临床决策。方法 :采用循证医学的方法 ,全面检索国内 1978年 1月～ 2 0 0 3年 2月中医药治疗BPH的临床研究文献 ,依据JADAD量表和试验分配的隐藏方案评价文献的质量。对纳入的文献进行资料合并的累加分析 (META分析 ) ,用Revman 4 .2软件进行统计和系统评价。　结果 :补肾活血类中药复方治疗BPH比前列康有效 (P <0 .0 0 0 0 1) ;与保列治相比疗效无差异 (P =0 .15 ) ;补肾活血类中药复方合用外科治疗与单纯外科治疗相比疗效无差异 (P =0 .0 7)。 4篇文献报道了不良反应 ,包括腹部不适、恶心腹胀、腹痛腹泻、鼻干。　结论 :应该进行大规模、多中心、随机对照的临床试验 ,并以客观指标为疗效评价标准来研究中医药治疗BPH的有效方法 ,评价药物不良反应。更多还原

【Abstract】 Objective: To make a system review of the effects of Bushenhuoxue (kidney-tonifying and blood-activating prescription), a category of compound Chinese medicines, on benign prostatic hyperplasia (BPH) and its side effects. Methods: All the reasearch articles about Chinese medicines treating BPH from January 1978 to February 2003 were retrieved using the methods of international evidence-based medicine (EBM), and their qualities were evaluated based on JADAD standard and concealment of research allocation. Then the included articles went through META-analysis with Revman 4.2 software. Results: The efficacy of Bushenhuoxue on BPH was better than Qianliekang but not statistically different from finasteride. The combined use of Bushenhuoxue with surgery had no statistical difference from mere surgical treatment. Four articles reported the side effects of this compound Chinese medicine including upset and pain in the abdomen, nausea, diarrhea and dryness of the nose. Conclusion: Massive, multi-center and randomized controlled clinical trials should be conducted to find out more effective methods for treating BPH with Chinese medicines based on the improvement of measurable symptom evaluation method and for evaluating their side effects.更多还原